Carriage (CSV) Q4 2025 Earnings Transcript

Carriage Services reported Q4 revenue of $105.5 million, up 8% year over year, with adjusted EBITDA rising 11% to $32.5 million and adjusted diluted EPS increasing 21% to $0.75. Full-year revenue grew 3.3% to $417.4 million, while 2026 guidance calls for $440 million-$450 million in revenue, $135 million-$140 million of adjusted EBITDA, and $3.35-$3.55 of adjusted EPS. The call was constructive, but margin/FCF headwinds from higher CapEx, incentive pay, and a $1.2 million medical claims expense, plus delays in Project Trinity, temper the outlook.

Analysis

CSV’s setup is less about one clean beat and more about a credible re-rating of durability: the company is showing that low-growth end markets can still compound if mix, pricing, and pre-need conversion keep improving. The important second-order effect is that higher cemetery development spend is not just a drag on free cash flow; it is a deliberate reinvestment to widen the moat around local inventory, which should support pricing power and reduce reliance on external M&A over time. That matters because the company’s stated consolidation posture only works if its core cash engine can self-fund a steady acquisition cadence without leverage drifting above target.

The market should focus on the tension between reported margin resilience and the near-term step-up in overhead and capex. If Trinity slips again, the downside is not just delayed efficiency gains; it risks creating a multi-quarter period where investors pay for transformation costs without seeing operating leverage, which can compress the multiple even if earnings still rise. The offset is that Sales Edge adoption is already functioning as a visible lead indicator for preneed throughput, so any incremental conversion there should show up earlier than a full Trinity benefit and can cushion the guide if Q1’s flu-driven comp looks noisy.

Consensus may underappreciate how much of the 2026 story is already de-risked by the balance-sheet reset and by the company’s ability to buy revenue at 7x-9x EBITDA while keeping leverage anchored near 4x. That creates a fairly asymmetric setup: if acquisitions land and integrate cleanly, earnings can outgrow revenue; if deal flow slows, the stock still has a de-levering and cash conversion story. The main failure mode is not demand, but execution fatigue — too much simultaneous spend on IT, M&A integration, and field incentives could mute the expected operating leverage and turn a good compounder into a persistent 4x leverage story with limited multiple expansion.

Key Decisions for Investors

• Long CSV on a 3-6 month horizon into the next acquisition update; upside comes from multiple expansion if investors start capitalizing M&A as repeatable, while downside is limited by leverage staying near target and cash flow still positive.
• Buy CSV call spreads or use a bullish risk reversal into the next quarterly print if implied volatility is cheap; the trade is on a clean beat-and-raise path if pre-need momentum offsets the tough Q1 comp.
• Pair trade: long CSV / short a slower-growth funeral-services peer with weaker acquisition discipline over the next 1-2 quarters; CSV should outperform if the market rewards visible consolidation and self-funded growth.
• If already long CSV, hedge with a short-dated put spread through the next earnings date because the main near-term risk is not fundamentals but schedule slippage on Trinity causing narrative disappointment.
• On pullbacks tied to Q1 volume noise, add to CSV rather than chase strength; the cleaner entry is after the market prices in the flu-related comp and before M&A announcements re-rate the story.